Annual Gross Profit
$27.12 M
+$27.12 M+100.00%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual gross profit is $27.12 million, with the most recent change of +$27.12 million (+100.00%) on December 31, 2023.
- During the last 3 years, AVDL annual gross profit has risen by +$10.53 million (+63.43%).
- AVDL annual gross profit is now -83.22% below its all-time high of $161.60 million, reached on December 31, 2015.
Performance
AVDL Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$43.87 M
+$5.15 M+13.31%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly gross profit is $43.87 million, with the most recent change of +$5.15 million (+13.31%) on September 30, 2024.
- Over the past year, AVDL quarterly gross profit has increased by +$25.11 million (+133.85%).
- AVDL quarterly gross profit is now -9.74% below its all-time high of $48.60 million, reached on March 31, 2017.
Performance
AVDL Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$127.00 M
+$36.97 M+41.07%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM gross profit is $127.00 million, with the most recent change of +$36.97 million (+41.07%) on September 30, 2024.
- Over the past year, AVDL TTM gross profit has increased by +$99.89 million (+368.35%).
- AVDL TTM gross profit is now -23.83% below its all-time high of $166.73 million, reached on September 30, 2017.
Performance
AVDL TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
AVDL Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | +133.8% | +368.4% |
| 3 y3 years | +63.4% | +2904.8% | +8598.8% |
| 5 y5 years | -68.4% | +2904.8% | +8598.8% |
AVDL Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | -42.4% | -100.0% | at high | -100.0% | at high | -100.0% |
| alltime | all time | -83.2% | -100.0% | -9.7% | +608.2% | -23.8% | -100.0% |
Avadel Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $43.87 M(+13.3%) | $127.00 M(+41.1%) |
| Jun 2024 | - | $38.72 M(+50.9%) | $90.03 M(+70.6%) |
| Mar 2024 | - | $25.66 M(+36.8%) | $52.77 M(+94.6%) |
| Dec 2023 | $27.12 M(>+9900.0%) | $18.76 M(+172.0%) | $27.12 M(+224.5%) |
| Sep 2023 | - | $6.90 M(+372.4%) | $8.36 M(+472.4%) |
| Jun 2023 | - | $1.46 M(>+9900.0%) | $1.46 M(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $0.00(-100.0%) | - | - |
| Dec 2020 | $16.59 M(-64.8%) | $0.00(0.0%) | $16.59 M(-34.1%) |
| Sep 2020 | - | $0.00(-100.0%) | $25.17 M(-31.2%) |
| Jun 2020 | - | $6.81 M(-30.5%) | $36.58 M(-16.3%) |
| Mar 2020 | - | $9.79 M(+14.0%) | $43.70 M(-7.2%) |
| Dec 2019 | $47.09 M(-45.1%) | $8.58 M(-24.8%) | $47.09 M(-14.6%) |
| Sep 2019 | - | $11.41 M(-18.1%) | $55.14 M(-8.8%) |
| Jun 2019 | - | $13.93 M(+5.8%) | $60.44 M(-16.3%) |
| Mar 2019 | - | $13.17 M(-20.8%) | $72.22 M(-15.8%) |
| Dec 2018 | $85.75 M(-45.4%) | $16.63 M(-0.5%) | $85.75 M(-14.1%) |
| Sep 2018 | - | $16.71 M(-35.0%) | $99.83 M(-16.1%) |
| Jun 2018 | - | $25.72 M(-3.7%) | $119.01 M(-11.9%) |
| Mar 2018 | - | $26.70 M(-13.0%) | $135.04 M(-14.0%) |
| Dec 2017 | $156.94 M(+14.6%) | $30.70 M(-14.4%) | $156.94 M(-5.9%) |
| Sep 2017 | - | $35.88 M(-14.0%) | $166.73 M(+4.1%) |
| Jun 2017 | - | $41.75 M(-14.1%) | $160.09 M(+4.4%) |
| Mar 2017 | - | $48.60 M(+20.0%) | $153.29 M(+11.9%) |
| Dec 2016 | $137.00 M(-15.2%) | $40.49 M(+38.5%) | $137.00 M(-0.8%) |
| Sep 2016 | - | $29.24 M(-16.3%) | $138.13 M(-10.4%) |
| Jun 2016 | - | $34.95 M(+8.2%) | $154.12 M(-6.6%) |
| Mar 2016 | - | $32.31 M(-22.4%) | $165.01 M(+2.0%) |
| Dec 2015 | $161.60 M(+1294.1%) | $41.63 M(-7.9%) | $161.80 M(+43.2%) |
| Sep 2015 | - | $45.23 M(-1.4%) | $112.98 M(+55.0%) |
| Jun 2015 | - | $45.85 M(+57.6%) | $72.86 M(+136.3%) |
| Mar 2015 | - | $29.10 M(-504.6%) | $30.83 M(+456.6%) |
| Dec 2014 | $11.59 M(+220.5%) | -$7.19 M(-240.6%) | $5.54 M(+35.2%) |
| Sep 2014 | - | $5.12 M(+34.2%) | $4.10 M(+44.8%) |
| Jun 2014 | - | $3.81 M(+0.2%) | $2.83 M(-13.6%) |
| Mar 2014 | - | $3.81 M(-144.1%) | $3.28 M(-9.4%) |
| Dec 2013 | $3.62 M(-49.3%) | -$8.63 M(-324.4%) | $3.62 M(-27.0%) |
| Sep 2013 | - | $3.85 M(-9.7%) | $4.96 M(-1.0%) |
| Jun 2013 | - | $4.26 M(+2.7%) | $5.01 M(-4.4%) |
| Mar 2013 | - | $4.14 M(-156.8%) | $5.24 M(-26.6%) |
| Dec 2012 | $7.13 M | -$7.29 M(-287.1%) | $7.13 M(-66.4%) |
| Sep 2012 | - | $3.90 M(-13.1%) | $21.23 M(-20.3%) |
| Jun 2012 | - | $4.49 M(-25.8%) | $26.63 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $6.04 M(-11.1%) | $26.96 M(+2.5%) |
| Dec 2011 | $26.32 M(-12.8%) | $6.80 M(-26.9%) | $26.32 M(-15.4%) |
| Sep 2011 | - | $9.30 M(+93.1%) | $31.10 M(+9.9%) |
| Jun 2011 | - | $4.82 M(-10.6%) | $28.30 M(-3.8%) |
| Mar 2011 | - | $5.39 M(-53.4%) | $29.41 M(-2.5%) |
| Dec 2010 | $30.18 M(-5.7%) | $11.58 M(+78.0%) | $30.18 M(+18.0%) |
| Sep 2010 | - | $6.51 M(+9.7%) | $25.58 M(-3.1%) |
| Jun 2010 | - | $5.93 M(-3.8%) | $26.40 M(-6.2%) |
| Mar 2010 | - | $6.16 M(-11.7%) | $28.16 M(-12.0%) |
| Dec 2009 | $32.00 M(+10.4%) | $6.98 M(-4.8%) | $32.00 M(-0.4%) |
| Sep 2009 | - | $7.33 M(-4.6%) | $32.13 M(+2.6%) |
| Jun 2009 | - | $7.68 M(-23.2%) | $31.32 M(+2.5%) |
| Mar 2009 | - | $10.00 M(+40.7%) | $30.55 M(+5.3%) |
| Dec 2008 | $29.00 M(+50.0%) | $7.11 M(+9.0%) | $29.00 M(+5.2%) |
| Sep 2008 | - | $6.52 M(-5.6%) | $27.56 M(+6.8%) |
| Jun 2008 | - | $6.91 M(-18.3%) | $25.81 M(+14.0%) |
| Mar 2008 | - | $8.46 M(+49.1%) | $22.64 M(+17.1%) |
| Dec 2007 | $19.33 M(+15.3%) | $5.67 M(+18.9%) | $19.33 M(-3.8%) |
| Sep 2007 | - | $4.77 M(+27.1%) | $20.09 M(+6.4%) |
| Jun 2007 | - | $3.75 M(-27.1%) | $18.89 M(+1.2%) |
| Mar 2007 | - | $5.14 M(-19.9%) | $18.67 M(+13.3%) |
| Dec 2006 | $16.77 M(-20.4%) | $6.43 M(+80.4%) | $16.48 M(+4.4%) |
| Sep 2006 | - | $3.56 M(+0.9%) | $15.78 M(+8.5%) |
| Jun 2006 | - | $3.53 M(+19.5%) | $14.55 M(-10.5%) |
| Mar 2006 | - | $2.95 M(-48.5%) | $16.26 M(-22.8%) |
| Dec 2005 | $21.07 M(-59.3%) | $5.74 M(+146.2%) | $21.07 M(-36.3%) |
| Sep 2005 | - | $2.33 M(-55.5%) | $33.08 M(-23.4%) |
| Jun 2005 | - | $5.24 M(-32.6%) | $43.19 M(-6.2%) |
| Mar 2005 | - | $7.77 M(-56.2%) | $46.06 M(-11.1%) |
| Dec 2004 | $51.81 M(+141.1%) | $17.75 M(+42.7%) | $51.81 M(+6.1%) |
| Sep 2004 | - | $12.43 M(+53.3%) | $48.83 M(+20.0%) |
| Jun 2004 | - | $8.11 M(-40.0%) | $40.68 M(+10.4%) |
| Mar 2004 | - | $13.52 M(-8.5%) | $36.85 M(+43.0%) |
| Dec 2003 | $21.49 M(+34.0%) | $14.77 M(+244.9%) | $25.77 M(+104.4%) |
| Sep 2003 | - | $4.28 M(0.0%) | $12.61 M(-11.4%) |
| Jun 2003 | - | $4.28 M(+75.6%) | $14.23 M(+43.0%) |
| Mar 2003 | - | $2.44 M(+51.6%) | $9.95 M(+32.5%) |
| Dec 2002 | $16.03 M(+46.8%) | $1.61 M(-72.7%) | $7.51 M(+27.3%) |
| Sep 2002 | - | $5.90 M(+436.4%) | $5.90 M(+436.4%) |
| Dec 2001 | $10.92 M(+19.3%) | - | - |
| Dec 2000 | $9.15 M(+2.2%) | - | - |
| Dec 1999 | $8.95 M(+49.5%) | - | - |
| Dec 1998 | $5.99 M(+19.8%) | - | - |
| Mar 1998 | - | $1.10 M(-50.0%) | $1.10 M(-50.0%) |
| Dec 1997 | $5.00 M(+11.1%) | - | - |
| Dec 1996 | $4.50 M | - | - |
| Mar 1996 | - | $2.20 M | $2.20 M |
FAQ
- What is Avadel Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual gross profit year-on-year change?
- What is Avadel Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly gross profit year-on-year change?
- What is Avadel Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM gross profit year-on-year change?
What is Avadel Pharmaceuticals annual gross profit?
The current annual gross profit of AVDL is $27.12 M
What is the all time high annual gross profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual gross profit is $161.60 M
What is Avadel Pharmaceuticals annual gross profit year-on-year change?
Over the past year, AVDL annual gross profit has changed by +$27.12 M (+100.00%)
What is Avadel Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of AVDL is $43.87 M
What is the all time high quarterly gross profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly gross profit is $48.60 M
What is Avadel Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, AVDL quarterly gross profit has changed by +$25.11 M (+133.85%)
What is Avadel Pharmaceuticals TTM gross profit?
The current TTM gross profit of AVDL is $127.00 M
What is the all time high TTM gross profit for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM gross profit is $166.73 M
What is Avadel Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, AVDL TTM gross profit has changed by +$99.89 M (+368.35%)